c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells

Leukemia

Volumn 26, Issue 4, 2012, Pages 644-653

  Waldron, T ^a   De Dominici, M ^a   Soliera, A R ^a   Audia, A ^a   Iacobucci, I ^b   Lonetti, A ^b   Martinelli, G ^b   Zhang, Y ^c   Martinez, R ^c   Hyslop, T ^d   Bender, T P ^e   Calabretta, B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c PFIZER INC   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

oncogene; stem cells; transcription factor

Indexed keywords

ABELSON KINASE; BMI1 PROTEIN; PROTEIN C MYB; PROTEIN P190;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, B-CELL; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 7; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; REPRESSOR PROTEINS;

EID: 84859646296     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.264     Document Type: Article

References (39)

1. Gleissner B, Gokbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 2002; 99: 1536-1543. (Pubitemid 34533023)
2. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375-2384. (Pubitemid 26327486)
3. Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW et al. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 1988; 239: 775-777. (Pubitemid 18070931)
4. Lugo TG, Pendergast AM, Muller AJ, Witte ON. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079-1082.
5. Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 1995; 82: 981-988.
6. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247-254. (Pubitemid 26334856)
7. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J 1997; 16: 6151-6161. (Pubitemid 27458335)
8. Okuda K, Golub TR, Gilliland DG, Griffin JD. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene 1996; 13: 1147-1152. (Pubitemid 26343567)
9. Ilaria RL, Van Etten RA. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 1996; 271: 31704-31710. (Pubitemid 26408636)
10. Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399-1412. (Pubitemid 29227526)
11. Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 2004; 36: 453-461. (Pubitemid 38620028)
12. Xie S, Lin H, Sun T, Arlinghaus RB. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 2002; 21: 7137-7146. (Pubitemid 35305600)
13. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667. (Pubitemid 39063268)
14. Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007; 12: 528-541. (Pubitemid 350199070)
15. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776-779.
16. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K et al. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002; 30: 48-58.
17. Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 2001; 104: 21-32. (Pubitemid 32144969)
18. Yang MY, Liu TC, Chang JG, Lin PM, Lin SF. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 2003; 101: 3205-3211.
19. Corradini F, Cesi V, Bartella V, Pani E, Bussolari R, Candini O, Calabretta B. Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant Myb mutants. J Biol Chem 2005; 280: 30254-30262. (Pubitemid 41216205)
20. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of Myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 1991; 88: 2351-2355. (Pubitemid 21916414)
21. Ratajczak MZ, Hijiya N, Catani LK, DeRiel K, Luger SM, McGlave P et al. Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of Myb antisense oligodeoxynucleotides. Blood 1992; 79: 1956-1961.
22. Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. Requirement of Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 2008; 111: 4771-4779.
23. Lahortiga I, De Keersmaecker K, Van Vlierberghe PC, Graux C, Cauwelier B, Lambert F et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007; 39: 593-595. (Pubitemid 46676109)
24. Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayeuela JM, Dik WA et al. The MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007; 110: 1251-1261. (Pubitemid 47281423)
25. Lessard J, Sauvageau G. Bmi1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255-260. (Pubitemid 40852690)
26. Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005; 23: 275-286. (Pubitemid 41317795)
27. Heisterkamp N, Jenster G, Ten Hoeve J, Zovich D, Pattengale PK, Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature 1990; 344: 251-253.
28. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor Myb. Cell 2007; 131: 146-159. (Pubitemid 47498525)
29. Alkema MJ, Jacobs H, van Lohuizen M, Berns A. Perturbation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene 1997; 15: 899-910. (Pubitemid 27399551)
30. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999; 13: 2678-2690. (Pubitemid 29508555)
31. Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi1 and c-Myc oncoproteins. Mol Biol Cell 2007; 18: 536-546. (Pubitemid 46213222)
32. Evans JL, Moore TL, Kuehl WM, Bender T, Ting JP. Functional analysis of Myb protein in T-lymphocytic cell lines shows that it transactivates the c-myc promoter.Mol Cell Biol 1990; 10: 5747-5752.
33. Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV et al. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). J Cell Physiol 1996; 166: 618-630.
34. Mavilio F, Sposi NM, Petrini M, Bottero L, Matinucci M, De Rossi G et al. Expression of cellular oncogenes in primary cells from human acute leukemias. Proc Natl Acad Sci USA 1986; 83: 4394-4398. (Pubitemid 16057054)
35. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
36. Rizo A, Olthof S, Han L, Vellenga E, de Haan G, Schuringa JJ. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood 2009; 114: 1498-1505.
37. Haupt Y, Bath ML, Harris AW, Adams JM. Bmi1 transgene induces lymphomas and collaborates with Myc in tumorigenesis. Oncogene 1993; 8: 3161-3164. (Pubitemid 23312924)
38. Warner JK, Wang JC, Takenaka K, Doulatov S, McKenzie JL, Harrington L et al. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 2005; 19: 1794-1805. (Pubitemid 41486158)
39. Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M et al. Bmi1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res 2007; 67: 10286-10295. (Pubitemid 350070802)